The aim of this study was to synthesis and evaluation of the topical anti-inflammatory activity of 
Anti-inflammatory agents are used in the treatment of inflammation. There are two main types of antiinflammatory agents; Glucocorticosteroids and Non-Steroidal Anti-inflammatory Drugs (NSAIDs). The NSAIDs is so named because they do not belong to the steroidal groups and ceases discomfort by blocking the pathway of cyclo-oxygenase enzyme that creates prostaglandins and lessen the pain in different parts of the body. While the steroids reduces the inflammation by binding to cortisol receptors.
Many therapeutic agents from synthetic source have advantages and disadvantages which limits their usefulness on long term basis. Similarly, NSAIDs also shows many side effects includes stomach ulcers, bleeding ulcers, kidney dysfunction, constipation, dizziness and headaches. (2) So, application of the drug on the affected site or the nearby area is reasonable, since drugs produce effects after they reach the affected site. Topical non-steroidal anti inflammatory drugs (NSAIDs) are applied on the skin in the form of ointment, gel, cream or spray in the region where pain is located (3) . They have to penetrate the skin, enter tissues or joints, and at high concentration to have an effect on the inflammation process causing pain. The inhibitory activities of NSAID ointment on inflammatory responses were almost the same as
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those obtained by oral administration of such NSAID and more potent than those of steroidal ointment (4) So, the aim of this study is to develop a compound that have anti inflammatory effect, applied topically to reduce the side effects.
MATERIALS AND METHODS:
Chemical synthesis Synthesis of compound I (1E,4E)-1,5-diphenylpenta-1.4-dien-3-one: To a solution 10 mL of 3 M sodium hydroxide solution , 16 mL of 95% ethanol and 2.12 g (20 mmole) of benzaldehyde, add 0.58 g (10 mmole) of acetone and shake the mixture. The benzaldehyde, initially insoluble, goes into solution, resulting in a clear, pale-yellow solution. After a minute it suddenly becomes cloudy, and a yellow precipitate product forms. Continue to shake the beaker for the next 10 min. Remove the liquid from the beaker and add 30 mL of water and shake it vigorously. Remove the wash liquid and wash the crystals twice with 20-mL portions of water and then filtration by vacuum , drying and recrystalized from hot ethanol. The yield was about 78% and the melting point was 111-112°C. Method of preparation of ointment (6) Ointment was prepared by melting together petrolatum, Polyethylene glycol-3000, propylene glycol and menthol on a hot plate (70 ºC). The compound II was dissolved in it under stirring and cooled. Various compositions of ointment formulations were mentioned in the Table1.
Anti-inflammatory activity:
Carrageenan-induced rat paw edema (7) Anti-inflammatory activity was carried out using carrageenan-induced rat paw edema. The rats weighing between 150-200 g were selected randomly excluding pregnant female rats for the test. Animals were divided into different groups with six animals in each group. One group of rats were treated with ointment base which served as control, other group was treated with standard ointment (0.1% diclofenac sodium in ointment base). Remaining groups were treated with formulated ointment (F1-F5). 0.2 g of ointment was applied to the plantar surface of the hind paw by gentle rubbing 50 times with index finger. After 30 min 0.1 ml of 1% w/v of carrageenan was injected in the plantar region of the left paw of rats. The paw volumes were noted for 1, 2, 3, and 4h after carrageenan injection. The results were tabulated in Table 2 . The percentage edema inhibition by the drug was calculated by the formula: Percentage edema inhibition = [1-( Vt / Vc)] X 100% Where Vt: -is edema volume in drug treated group. Vc: -is edema volume in the control group
Xylene induced rat ear edema
The effect of the product on acute edema was assessed by using xylene induced ear edema in rats as described by M. A. Dkhil et al (8) The animals were divided into six groups each of six animals. 50l of xylene was applied to the anterior and posterior surfaces of the two ears under light ether anesthesia. After 15 minutes, 0.1 g of the formulated ointment (F1-F5) were applied on the right ears of five groups ,the sixth group receive 0.1 g diclofenac sodium (standard). The left ear was considered as control and receive ointment base only. Four-hour later xylene application rats were sacrificed and both ears were removed. Ear lobes were punched out in circular disc using metal punch (6 mm diameter) and weighed. The difference in the weight of discs from right treated and left untreated was calculated and was used as measure of edema. The results were tabulated in Table 3 
STATISTICAL ANALYSIS:
The results were expressed in mean± SEM. The data from experiments were analyzed separately using one-way Anova followed by Dunnett test was used to determine significant difference between the groups and p<0.05 was considered significant.
RESULTS
Statistical analysis showed that, the edema inhibition was significantly different from control group at all the tested concentrations. The results showed that the anti-inflammatory effect was more for the formulations containing 4% and 5% of the tested compound.
DISCUSSION:
Different formulations (F1-F5) were prepared by keeping the ointment base constant and changing the drug ratio (1-5%). All the formulations were stable for evaluation of anti-inflammatory activity. Anti-inflammatory activity was carried out for the formulated compounds using carrageenan-induced rat paw edema method and xylene induced rat ear edema Carrageenan-induced paw edema in rat and xylene induced rat ear edema has been accepted as a useful tool for investigating anti-inflammatory agents. It is suggested that there are biphasic effects in carrageenan-induced edema. The early hyperemia results from the release of histamine and serotonin, the delayed phase of carrageenan-induced edema results mainly from the potentiating effects of bradykinin on mediator release, and also from prostaglandins which produce edema after the mobilization of leukocytes (9) . The edema was reached its highest thickness 4 h after the application of the stimulus. (10) The compound II promoted a significant and dosedependent inhibition of xylene induced skin inflammation. Topically applied xylene resulted in activation of pro-inflammatory mediators that promoted the manifestation of several inflammatory parameters similar to some skin disorders (11.) . Using this model, compounds that inhibit this process can be target in the search for new therapeutic strategies.
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CONCLUSION:
From this result, we conclude that topical preparation containing 5% possesses good antiinflammatory activity which can be used for the treatment of topical inflammation.
